GDTC Stock Analysis: Buy, Sell, or Hold?
GDTC - CytoMed Therapeutics Limited Ordinary Shares
$0.89
-0.03 (-2.96%)
▼
5d:
-1.45%
30d:
-8.04%
90d:
-8.37%
HOLD
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When GDTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GDTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GDTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GDTC is currently trading at $0.89, which is considered oversold relative to its 30-day fair value range of $0.93 to $1.01.
Technical Outlook: Technically, GDTC is showing sideways momentum. Immediate support is located at $0.71, while resistance sits at $1.15.
Market Sentiment: GDTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+444.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GDTC is showing sideways momentum. Immediate support is located at $0.71, while resistance sits at $1.15.
Market Sentiment: GDTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+444.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.93 -
$1.01
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 444.0% below Wall St target ($5.00)
Trading Range Analysis
30-Day Trading Range
$0.93 -
$1.01
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$1.15
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Wall Street Target
$5.00
(+444.0%)
Revenue Growth (YoY)
46.9%
Share & Embed Analysis
Last updated: August 04, 2026 1:14 PM ET
Data refreshes hourly during market hours. Next update: 2:14 PM
Data refreshes hourly during market hours. Next update: 2:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GDTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
